AFFINITY Investigators, Coordination and Funding

AFFINITY brought together clinical investigators and participating stroke units to study fluoxetine after stroke. This page describes the people and institutions behind the research; the study design overview and protocol summary explain the study methods.

Investigators and Trial Coordination

The AFFINITY Trial was an investigator-driven study funded by the National Health and Medical Research Council (NHMRC). It was coordinated through the Stroke Research Group at the Harry Perkins Institute of Medical Research and Sir Charles Gairdner Hospital in Western Australia.

The trial’s Co-Principal Investigators were Associate Professor Maree Hackett, The George Institute for Global Health and The University of Sydney, and Professor Graeme Hankey, The University of Western Australia and Sir Charles Gairdner Hospital.

The trial coordinating centre worked with participating hospitals, stroke units and rehabilitation centres across Australia, New Zealand and Vietnam to support the implementation of the study protocol and follow-up procedures.

Research Funding

The National Health and Medical Research Council of Australia funded the study. The published primary trial report records the funding and the AFFINITY Trial Collaboration. The official trial registration provides the registered study details.

Completed Research

The trial recruited participants between January 2013 and June 2019. Read the trial overview and published results for the completed study findings, or use the contact page for research enquiries.